actavis.com Report : Visit Site

Technical data of the actavis.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host actavis.com. Currently, hosted in Israel and its service provider is TEVA .

the related websites

actavis.co.uk bloomberg.com actavisacademy.co.uk xpil.medicines.org.uk europages.co.uk ft.com medicines.org.uk sephora.com bewerleyhallfarm.co.uk dailymail.co.uk transfermarkt.co.uk albanytech.edu cartakeback.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Microsoft-IIS/8.5 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

-- pharmaceutical industries ltd. teva worldwide stock your browser does not support iframes. contact us hebrew see teva's sites around the world americas canada curacao united states growth markets argentina australia belarus brazil chile china india israel kazakhstan mexico peru russia singapore south africa turkey ukraine uruguay uzbekistan japan & s. korea japan south korea europe europe austria belgium bosnia & herzegovina bulgaria croatia czech republic denmark estonia finland france germany greece hungary ireland italy latvia lithuania macedonia netherlands norway poland portugal romania serbia slovakia slovenia spain sweden switzerland united kingdom see all see less want to find out more about teva's locations and phone numbers? visit teva worldwide life effects: amplifying the patient voice discover more connecting people living with ms discover more new app livestreams ms symposium discover more karaoke encore for parkinson’s patients discover more inside the brand discover more about about lobby company profile corporate officers corporate governance board of directors our history 2017 annual report – form 10-k quality notice of annual meeting of shareholders 2017 – proxy statement products products lobby specialty generic products generic faq over the counter (otc) api quality central nervous system (cns) respiratory research research lobby integrated r&d; our focus patient promise pipeline national network of excellence responsibility responsibility lobby social impact positions & policies patient advocacy social impact report multiple chronic conditions media media lobby latest news featured stories featured stories investors investors lobby news webcasts and presentations corporate governance financial information stock information shareholder information analysts coverage/consensus investor kit contact us careers careers lobby dare to be different our guiding values leadership development working at teva dare to be different search teva jobs teva worldwide stock contact us hebrew follow us: teva in action see what we’re doing and where all news top news may 23, 2018 teva confirms september pdufa date for fremanezumab learn more share top news may 18, 2018 correcting and replacing teva announces publication of phase iii trial data of fremanezumab for the preventive treatment of episodic migraine in the journal of the american medical association learn more share top news may 15, 2018 teva announces publication of phase iii trial data of fremanezumab for the preventive treatment of episodic migraine in the journal of the american medical association learn more share top news may 3, 2018 teva reports first quarter 2018 financial results learn more share top news may 2, 2018 teva to present austedo® (deutetrabenazine) tablets data at the american psychiatric association 2018 annual meeting learn more share healthcare heroes awards international awards program will recognize pioneering work in healthcare research and treatment. learn more featured stories take a closer look at what’s happening at teva all featured stories understanding every breath discover more earth day and every day our commitment to acting sustainably and treating the environment with respect learn more meeting the challenge of multiple chronic conditions learn more teva india shows staying power discover more safety first - our commitment learn more making a difference: teva social impact highlights discover more our unique perspective on health enables you to live better days specialized in cns & respiratory cutting-edge r&d uncompromising quality the world’s generic leader corporate responsibility about company profile corporate officers corporate governance board of directors our history products specialty generic products generic faq over the counter (otc) api quality research integrated r&d; our focus patient promise pipeline responsibility social impact positions & policies patient advocacy media latest news featured stories investors news webcasts and presentations corporate governance financial information stock information shareholder information analysts coverage/consensus investor kit contact us careers dare to be different our guiding values leadership development working at teva follow teva: legal notes data privacy tapi teva supplier code of conduct sitemap © 2015

URL analysis for actavis.com

http://www.tevapharm.com/
http://www.tevapharm.com/corporate_responsibility/social_impact/social_impact_report/
http://www.tevapharm.com/teva_worldwide/americas/
http://www.tevapharm.com/teva_worldwide/growth_markets/teva_in_singapore/
http://www.tevapharm.com/featuredstories/understanding_the_challenges_of_every_breath.aspx
http://www.tevapharm.com/?catid=%7bc34c0249-4cef-47b0-9c70-defbfd7bc4d8%7d
http://www.tevapharm.com/our_products/specialty_products/respiratory/
http://www.tevapharm.com/files/docs/teva_2016_social_impact_highlights.pdf
http://www.tevapharm.com/teva_worldwide/europe/
http://www.linkedin.com/sharearticle?mini=true&url=http://www.tevapharm.com/news/teva_announces_publication_of_phase_iii_trial_data_of_fremanezumab_for_the_preventive_treatment_of_episodic_migraine_in_the_journal_of_the_american_medical_association_05_18.aspx
http://www.tevapharm.com/research_development/rd_partnerships/patient_safety/
http://www.tevapharm.com/investor_relations/
http://www.tevapharm.com/?catid=%7bacb4607e-b266-4e46-8360-745dd4cab0da%7d
http://www.tevapharm.com/?catid=%7bca078113-4234-48bb-8c0b-8ba7c191e5b0%7d
http://www.tevapharm.com/news/teva_reports_first_quarter_2018_financial_results_05_18.aspx

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: actavis.com
Registry Domain ID: 89911203_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.comlaude.com
Registrar URL: http://www.comlaude.com
Updated Date: 2017-05-17T08:45:13Z
Creation Date: 2002-09-03T15:28:19Z
Registrar Registration Expiration Date: 2018-09-03T00:00:00Z
Registrar: NOM-IQ Ltd dba Com Laude
Registrar IANA ID: 470
Domain Status: clientDeleteProhibited https://www.icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://www.icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://www.icann.org/epp#clientUpdateProhibited
Registry Registrant ID:
Registrant Name: Actavis Inc.
Registrant Organization: Actavis Inc
Registrant Street: 400 Interpace Pkwy, Bldg A
Registrant City: Parsippany
Registrant State/Province: NJ
Registrant Postal Code: 07054
Registrant Country: US
Registrant Phone: +972.39267267
Registrant Phone Ext:
Registrant Fax:
Registrant Fax Ext:
Registrant Email: [email protected]
Registry Admin ID:
Admin Name: Domain Admin
Admin Organization: TEVA Pharmaceutical Industries Ltd.
Admin Street: 5 Basel Street
Admin City: Petach Tikva
Admin State/Province:
Admin Postal Code: 49131
Admin Country: IL
Admin Phone: +972.39267267
Admin Phone Ext:
Admin Fax: +972.39234050
Admin Fax Ext:
Admin Email: [email protected]
Registry Tech ID:
Tech Name: Technical Manager
Tech Organization: Com Laude
Tech Street: 28-30 Little Russell Street
Tech City: London
Tech State/Province: London
Tech Postal Code: WC1A 2HN
Tech Country: GB
Tech Phone: +44.2074218250
Tech Phone Ext:
Tech Fax: +44.8700118187
Tech Fax Ext:
Tech Email: [email protected]
Name Server: odinn.medis.is
Name Server: andromeda.medis.is
Name Server: ares.medis.is
DNSSEC: Unsigned Delegation
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +44.2074218250
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2017-07-18T11:20:08Z <<<

For more information on Whois status codes, please visit https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en

-------------------------------------------------------------------------------
Com Laude registers, maintains and renews domain names around the world for
leading intellectual property owners and the law firms that support them.
If you have queries about this domain, you may contact us via our website
at www.comlaude.com.
-------------------------------------------------------------------------------

The data in the Com Laude Whois database is provided to assist you in obtaining
information about a domain name registration record. Com Laude makes this
information available "as is," and does not guarantee its accuracy.
By submitting a WHOIS query, you agree that you will use this data only for
lawful purposes and that, under no circumstances will you use this data to:

(1) allow, enable, or otherwise support the transmission of mass unsolicited,
commercial advertising or solicitations via e-mail (spam), telephone or fax; or
(2) enable high volume, automated, electronic processes that that send queries
or data to Com Laude or the systems of any Registry Operator or ICANN-Accredited
registrar. The compilation, repackaging, dissemination or other use of this
data is expressly prohibited without the prior written consent of Com Laude.

Com Laude reserves the right to modify these terms at any time. By submitting
this query, you agree to abide by these terms. If you fail to abide by this
policy, we may terminate your access to this WHOIS database.

-------------------------------------------------------------------------------
Com Laude protects intellectual property in the domain name system. Com Laude
only registers domain names for legitimate rights owners. Should you have any
queries about the legitimacy of this name or our work as a UK based, ICANN
Accredited Registrar, contact us at:
Com Laude, 28-30 Little Russell Street, London WC1A 2HN, UK.
Com Laude is a business name of Nom IQ Ltd.
-------------------------------------------------------------------------------


  REGISTRAR NOM IQ LTD (DBA COM LAUDE)

  REFERRER http://www.comlaude.com

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =actavis.com

  PORT 43

  SERVER whois.comlaude.com

  ARGS actavis.com

  PORT 43

  TYPE domain

DOMAIN

  NAME actavis.com

NSERVER

  ANDROMEDA.MEDIS.IS 193.110.132.155

  ARES.MEDIS.IS 213.220.114.10

  ODINN.MEDIS.IS 209.143.183.136

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

  CHANGED 2016-11-08

  CREATED 2002-09-03

  EXPIRES 2018-09-03

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .